Niki BioSolutions, Inc. (NIKI): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$3.0K
Year ended 2023-12-31
-73.5%
3-year compound annual growth
-77.8%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $3.0K | -98.4% | 2026-03-27, From 2023-01-01 |
| 2022-12-31 | $186.9K | +41.9% | 2025-04-30, From 2022-01-01 |
| 2021-12-31 | $131.8K | -18.3% | 2024-04-30, From 2021-01-01 |
| 2020-12-31 | $161.3K | -80.7% | 2023-04-28, From 2020-01-01 |
| 2019-12-31 | $837.1K | -85.2% | 2023-01-17, From 2019-01-01 |
| 2018-12-31 | $5.65M | n/a | 2021-04-19, From 2018-01-01 |